pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Apr 28·1 min read
save

Devoted Health’s 2025 revenue slips in turbulent Medicare Advantage market

Devoted Health’s revenue and membership declined in 2025 for the first time since it launched health plans for seniors seven years ago. It’s a sign the high-profile startup, helmed by former Athenahealth executives and an ...

Apr 28, 2026·read at Endpoints ↗

April 28, 2026 09:00 AM EDT StartupsHealth Tech De­vot­ed Health’s 2025 rev­enue slips in tur­bu­lent Medicare Ad­van­tage mar­ket Shelby Livingston Health tech correspondent De­vot­ed Health’s rev­enue and mem­ber­ship de­clined in 2025 for the first time since it launched health plans for se­niors sev­en years ago. It’s a sign … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
83 words · retrieved Apr 29
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 48m agoItaly's Menarini gets into obesity with European rights to GLP-1 from China's Gan & LeeEndpoints
  • 16h agoMerck's top dealmaker signals more M&A as Keytruda's patent cliff nearsEndpoints
  • 20h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 20h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 20h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints